You are here Home Resources Handbook tables Handbook tables Table. Recommendations for MenB vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease Listen Print Share Twitter Facebook Email Age at start of vaccine course MenB vaccine brand Dose requirements for people with a specified medical condition associated with increased risk of meningococcal disease 6 weeks to 5 months Bexsero 4 doses (8 weeks between doses; 4th dose at 12 months of age or 8 weeks after 3rd dose, whichever is later) 6–11 months Bexsero 3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) 12 months to 9 years Bexsero 2 doses (8 weeks between doses) ≥10 years Bexsero 2 doses (8 weeks between doses) Trumenba 3 doses (at intervals of 0, 1 and 6 months) Page history Last updated 5 June 2018 Last reviewed 5 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank